Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

AstraZeneca and Scorpion strike $1.5bn deal against hard-to-treat proteins

January 14, 2022 Medical Communications

AstraZeneca and Scorpion have partnered to develop precision medicines against previously hard-to-target cancer proteins. The collaboration, valued at more than …
News

South Africa study shows J&J booster 85% effective against Omicron hospitalisation

January 14, 2022 Medical Communications

The head of South Africa’s Medical Research Council (SAMRC) has revealed that a J&J booster shot is 85% effective in …
News

First melanoma test to offer reassurance of low risk of cancer spread

January 14, 2022 Medical Communications

A new test reliably predicting the spread or return of the most deadly form of skin cancer has been developed …
News

WHO recommend two new COVID-19 treatments

January 14, 2022 Medical Communications

WHO approved two new treatments for COVID-19 on 14 January, as Omicron cases continue globally, and WHO predicting half of …
News
mufid-majnun-oi20ehignd4-unsplash

Canada to procure 20,000 doses of GSK COVID-19 antibody therapy

January 7, 2022 Medical Communications

GlaxoSmithKline Plc. has shared that it has signed agreements with the Government of Canada to supply 20,000 doses of Sotrovimab, …
News

Judge orders FDA to produce Pfizer safety data in eight months

January 7, 2022 Medical Communications

A federal judge has ordered the FDA to make public tens of thousands of more pages on the data it …
News

J&J COVID-19 vaccine shows protection against breakthrough infection for up to six months

January 7, 2022 Medical Communications

J&J have announced new results from the largest study to date on the durability of COVID-19 vaccines in the US. …
News

Neurimmune and AstraZeneca collaborate to develop human monoclonal antibody

January 7, 2022 Medical Communications

Neurimmune AG announced that it has entered into an exclusive global collaboration and license agreement with Alexion, AstraZeneca Rare Disease …
News
nice

NICE recommends combination treatment for patients with multiple myeloma

December 24, 2021 Medical Communications

NICE has recommended the use of Darzalex (daratumumab) in combination with Velcade (bortezomib), thalidomide and dexamethasone (DVTd) as induction and …
News

MHRA approves license extension for Novartis’ breast cancer targeted therapy

December 24, 2021 Medical Communications

The MHRA has approved the marketing authorisation to extend Novartis’ licence in Great Britain for Piqray (alpelisib), for use in …
News
moderna_norwood_plant

Moderna CEO says Omicron booster could begin development within weeks

December 21, 2021 Medical Communications

Stephane Bancel, CEO of Moderna, said that the company could begin work on a booster shot against the Omicron variant …
News

Vifor Pharma announces positive results from Phase IIIb trial of heart failure treatment

December 21, 2021 Medical Communications

Vifor Pharma has announced positive findings for the completed Phase IIIb DIAMOND trial of Veltassa, in heart failure patients with …
News

CDC recommends mRNA vaccines over J&J

December 17, 2021 Medical Communications

The CDC has recommended Pfizer-BioNTech and Moderna COVID-19 vaccines over Johnson & Johnson jabs. The recommendation from CDC Director Dr …
News

COVID-19 booster vaccine triggers immune response in days, not weeks, scientists say

December 17, 2021 Medical Communications

COVID-19 booster jabs trigger an immune response in a matter of days, rather than weeks, scientists have shared. Data suggests …
News

NICE recommends offering PrEP to those at high risk of HIV

December 17, 2021 Medical Communications

People at the highest risk of catching HIV should be offered Pre Exposure Prophylaxis (PrEP), NICE has recommended for the …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025